Hi friends
Chris and others have already pointed you to this pithy interview on Medscape but I found it compelling and tried to fill in some commentary and context and references on my blog bkoffman.blogspot.com
Stay strong
Brian
ASH 2014: Interview with Dr. Susan O'Brien and... - CLL Support
ASH 2014: Interview with Dr. Susan O'Brien and Dr. Bruce Cheson on CLL
Written by
bkoffman
CLL CURE Hero
To view profiles and participate in discussions please or .
Not what you're looking for?
You may also like...
ASCO 2014: Dr. Susan O'Brien Reviews the 3 years follow-up Data on Ibrutinib in CLL
Friends,
I am stuck at the airport on my way to OSU waiting for my delayed flight, so I thought I...
ASH 2013: INTERVIEW WITH DR. FURMAN RE: IDELALISIB
Hi friends
In my last blog post ( http://bkoffman.blogspot.com ), I have a short and interesting...
Dr. O'Brien on Trial Design, CT scans and the one and only place for FCR.
Friends,
Please check out my blog: http://bkoffman.blogspot.com to hear my last interview from...
ASH 2014. Dr. Sharman discusses the biology of our CLL cells
Friends,
This week on the CLL Society website http://cllsociety.org, we share the first part of an...
ASH 2015: Dr. John M Pagel on the Problems with Idelalisib as Frontline Therapy in CLL
It has been a while since I posted an interview on my blog first instead of the CLL Society...
Related Posts
- ASH 2016: Dr. Mato on real world data on ibrutinib
- ASH 2013: Dr. John Pagel Speculates on the Future of CLL Therapies including the late breaking data on Idelalisib
Exciting times in CLL: an ASCO 2013 interview with Dr Susan O’Brien- Part 2 of ASH Interview with Dr. Sharman, a patient meeting in Seattle and off to iwCLL later tonight
ASH 2012 Interview: Dr Jeff Sharman "Why New CLL Treatments Supersede FCR"
